Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cichocka-Jarosz

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Przeglad Lekarski|January 1, 1996
[Value of selected parameters for monitoring efficacy of specific immunotherapy in allergic disorders]E Cichocka-Jarosz
Allergie Et Immunologie|December 10, 1998
Induction of allergy to new aeroallergens during specific immunotherapy (SIT) in grass pollen sensitive patientsK Obtulowicz, E Cichocka-Jarosz
Pediatric Pulmonology|October 1, 1995
Congenital stridorG Lis, T Szczerbinski, E Cichocka-Jarosz
Przeglad Lekarski|January 1, 1997
[Pollen allergy. I. Pathophysiology and clinic]E Cichocka-Jarosz, G Lis, J J Pietrzyk
Przeglad Lekarski|January 1, 1997
[Diagnostic value of selected eosinophil activity parameters in children with hay fever]E Cichocka-Jarosz, G Lis, J J Pietrzyk
Przeglad Lekarski|January 1, 1997
[Pollen allergy. II. Diagnosis and treatment]E Cichocka-Jarosz, G Lis, J J Pietrzyk
Przeglad Lekarski|January 1, 1992
[Foreign bodies in respiratory tracts of children treated at the Institute of Pediatrics in Krakow during the years 1987-1991]G Lis, K Kobylarz, E Cichocka-Jarosz, et al.
Pneumonologia I Alergologia Polska|December 6, 2001
[Montelukast in treatment mild chronic asthma]G Lis, E Cichocka-Jarosz, I Głodzik, et al.
Przeglad Lekarski|January 1, 1997
[Bronchial asthma: do boys or girls have the highest incidence?]G Lis, J J Pietrzyk, E Cichocka-Jarosz, et al.
Journal of Investigational Allergology & Clinical Immunology|July 5, 2011
Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in childrenE Cichocka-Jarosz, M Sanak, A Szczeklik, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Przeglad Lekarski|January 1, 1996
[Value of selected parameters for monitoring efficacy of specific immunotherapy in allergic disorders]E Cichocka-Jarosz
Allergie Et Immunologie|December 10, 1998
Induction of allergy to new aeroallergens during specific immunotherapy (SIT) in grass pollen sensitive patientsK Obtulowicz, E Cichocka-Jarosz
Pediatric Pulmonology|October 1, 1995
Congenital stridorG Lis, T Szczerbinski, E Cichocka-Jarosz
Przeglad Lekarski|January 1, 1997
[Pollen allergy. I. Pathophysiology and clinic]E Cichocka-Jarosz, G Lis, J J Pietrzyk
Przeglad Lekarski|January 1, 1997
[Diagnostic value of selected eosinophil activity parameters in children with hay fever]E Cichocka-Jarosz, G Lis, J J Pietrzyk
Przeglad Lekarski|January 1, 1997
[Pollen allergy. II. Diagnosis and treatment]E Cichocka-Jarosz, G Lis, J J Pietrzyk
Przeglad Lekarski|January 1, 1992
[Foreign bodies in respiratory tracts of children treated at the Institute of Pediatrics in Krakow during the years 1987-1991]G Lis, K Kobylarz, E Cichocka-Jarosz, et al.
Pneumonologia I Alergologia Polska|December 6, 2001
[Montelukast in treatment mild chronic asthma]G Lis, E Cichocka-Jarosz, I Głodzik, et al.
Przeglad Lekarski|January 1, 1997
[Bronchial asthma: do boys or girls have the highest incidence?]G Lis, J J Pietrzyk, E Cichocka-Jarosz, et al.
Journal of Investigational Allergology & Clinical Immunology|July 5, 2011
Serum tryptase level is a better predictor of systemic side effects than prostaglandin D2 metabolites during venom immunotherapy in childrenE Cichocka-Jarosz, M Sanak, A Szczeklik, et al.
Pageof 2